PLYMOUTH
MEETING, Pa., Sept. 13,
2023 /PRNewswire/ -- Harmony Biosciences Holdings,
Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical
company dedicated to developing and commercializing innovative
therapies for patients with rare neurological diseases, today
announced that Harmony's management team will participate in a
fireside chat at the upcoming 2023 Cantor Global Healthcare
Conference in New York, NY on
Wednesday, September 27, 2023, at
10:20 a.m. ET.
A webcast of the fireside chat will be available on the investor
page of Harmony's website at
https://ir.harmonybiosciences.com/.
About Harmony Biosciences
At Harmony Biosciences, we
specialize in developing and delivering treatments for rare
neurological diseases that others often overlook. We believe that
where empathy and innovation meet, a better life can begin for
people living with neurological diseases. Established by Paragon
Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, PA, our team of experts from
a wide variety of disciplines and experiences is driven by our
shared conviction that innovative science translates into
therapeutic possibilities for our patients, who are at the heart of
everything we do. For more information, please visit
www.harmonybiosciences.com.
Harmony Biosciences Investor Contact:
Luis Sanay, CFA
445-235-8386
lsanay@harmonybiosciences.com
Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
cmccanless@harmonybiosciences.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-2023-cantor-global-healthcare-conference-301924870.html
SOURCE Harmony Biosciences